French national multicentric phase III trial evaluating chemotherapy with Folfirinox or gemcitabine in locally advanced pancreatic carcinoma.
Comparative interventional prospective phase 3, randomized, open-label, multicentric trial comparing chemotherapy with Folfirinox to Gemcitabine in locally advanced pancreatic carcinoma.
| Condition | Pancreatic Cancer, Pancreatic Cancer, Islet Ce417ll Cancer, Pancreatic disorder, Pancreatic Disorders, Carcinoma, Vulvar Dysplasia and Carcinoma, Advanced Malignancies, Neoplasm of unspecified nature of digestive system, Digestive System Neoplasms, Pancreatic Disorders, Vulvar Dysplasia and Carcinoma, Advanced Malignancies, Islet Ce417ll Cancer, Digestive System Neoplasms, cancer of the pancreas, pancreatic cancers, cancer, pancreatic, carcinomas |
|---|---|
| Treatment | Gemcitabine, Irinotecan, Oxaliplatin, Folinic Acid, 5-Fluoro-uracil, L-folinic |
| Clinical Study Identifier | NCT02539537 |
| Sponsor | UNICANCER |
| Last Modified on | 5 March 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.